Zur Behandlung depressiver Störungen mit modernen Verfahren der Elektrokonvulsionstherapie

D. Klecha; M. Legler; M. Hüll

doi:10.1055/s-2002-32520

Fortschritte der Neurologie · Psychiatrie, Inhaltsverzeichnis

Fortschr Neurol Psychiatr 2002; 70(7): 353-367
DOI: 10.1055/s-2002-32520

Originalarbeit

Zur Behandlung depressiver Störungen mit modernen Verfahren der Elektrokonvulsionstherapie

Current Use of ECT in the Treatment of Depressive DisordersD. Klecha¹ , M. Legler² , M. Hüll¹

¹Abteilung für Psychiatrie und Psychotherapie des Universitätsklinikums Freiburg
²Anästhesiologische Universitätsklinik Freiburg

Abstract

Zusammenfassung

Die Elektrokrampftherapie ist bei adäquater Indikationsstellung ein sehr effektives und unter Berücksichtigung somatischer Begleiterkrankungen und bei sorgfältigem Management kardiovaskulärer Reaktionen peri- und post-EKT ein sicheres Verfahren. Insbesondere in Deutschland ist diese Therapieform dennoch nicht unumstritten. Im folgenden Artikel wird der gegenwärtige Wissensstand zur EKT-Behandlung, die Indikation, Durchführung, Nebenwirkungen sowie neuere Entwicklungen bezüglich des Einsatzes der EKT bei der Erhaltungstherapie dargestellt. Hiermit soll ein Beitrag zu einer Versachlichung der Diskussion um den Einsatz der EKT geleistet werden.

Abstract

If used with correct indication, electroconvulsive therapy (ECT) is a very effective and safe treatment for some forms of major depression, provided due consideration is given to possibly concomitant somatic conditions and that the cardiovascular reactions during and after the ECT treatments are managed carefully. Despite this, ECT remains controversial, especially in Germany. This article provides an overview of the current state of the art in ECT: appropriate indications, best practice in conducting ECT, side effects and recent developments in the use of ECT as maintenance therapy. This, it is hoped, will contribute to a more factually grounded discussion of the use of ECT.

Volltext

Referenzen

Literatur

1 Peters U H. Die Einführung der Schockbehandlungen und die psychiatrische Emigration. Fortschr Neurol Psychiat. 1992; 60 356-369
2 Kellner C H, Pritchett J T, Beale M D, Coffey C E. Handbook of ECT. Washington DC: American Psychiatric Press Inc 1997
3 Fink M. Electroshock. Restoring the mind. New York: Oxford University Press 1999
4 Fink M. Convulsive therapy: a review of the first 55 years. J of Affect Disord. 2001; 63 1-15
5 Hirschfeld R M. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs. J Clin Psychiatry. 1999; 60 326-335
6 Folkerts H W. Der Stellenwert der EKT bei therapieresistenten Depressionen. In: Bauer M, Berghöfer A (Hrsg). Therapieresistente Depressionen Berlin: Springer 1997: 187-185
7 The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging: A Task Force Report of the American Psychiatric Association. Washington DC: APA 1990
8 The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training and Privileging: A Task Force Report of the American Psychiatric Association. Second Edition. Washington DC: APA 2001
9 Praxisleitlinien in Psychiatrie und Psychotherapie. Band 5: Behandlungsleitlinie Affektive Erkrankungen. Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (Hrsg.). Darmstadt: Steinkopff 2000
10 Berger M. Affektive Erkrankungen. In: Berger M (Hrsg). Psychiatrie und Psychotherapie. München: Urban & Fischer 2000: 483-566
11 Abrams R. Electroconvulsive therapy. New York: Oxford University Press 1997
12 Scott A IF. The efficacy of electroconvulsive therapy. In: Checkley S (ed). The management of depression. Oxford: Blackwell Science 1998: 252-275
13 Jadad A R, Moore R A, Carroll D, Jenkinson C, Reynolds D J, Gavaghan D J, McQuay H J. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Conrolled clinical trials. 1996; 17 1-12
14 Selvan C P, Mayur P M, Gangadhar B N, Janakiramaiah N, Subbakrishna D K, Murali N. Comparison of the therapeutic efficacy of ECT and imipramine: a randomized controlled trial. Indian J Psychiatry. 1999; 41 228-235
15 Janakiramaiah N, Gangadhar B N, Naga Venkatesha Murthy P J, Harish M G, Subbakrishna D K, Vedamurthachar A. Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: a randomized comparison with electroconvulsive therapy (ECT) and imipramine. J Affect Disord. 2000; 57 255-259
16 Flint A J, Rifat S L. The treatment of psychotic depression in later life: A comparison of pharmacotherapy and ECT. Int J Geriatr Psychiat. 1998; 13 23-28
17 Folkerts H W, Tölle M N, Schonauer K, Mücke S, Schulze-Mönking H. Electroconvulsive therapy vs. paroxetine in treatment-resistant depression - a randomized study. Acta Psychiatr Scand. 1997; 96 334-342
18 Dubovsky S, Buzan R. Mood disorders. In: Hales R, Yudofsky SC, Talbott JA (eds). Textbook of Psychiatry Washington: American Psychiatric Press 1999: 479-567
19 Buchan H, Johnstone E, McPherson K, Palmer R L, Crow T J, Brandon S. Who benefits from electroconvulsive therapy? Combined results of the Leicester and Northwick Park Trials. Br J Psychiatry. 1992; 160 355-359
20 Hickie I, Mason C, Parker G, Brodaty H. Prediction of ECT response: validation of a refined sign-based (CORE) system for defining melancholia. Br J Psychiatry. 1996; 169 68-74
21 O'Leary D, Gill D, Gregory S, Shawcross C. Which depressed patients respond to ECT? The Nottingham results. J Affect Disord. 1995; 33 245-250
22 Sobin C, Prudic J, Devenand D P, Nobler M S, Sackeim H A. Who responds to electroconvulsive therapy? A comparison of effective and ineffective forms of treatment. Br J Psychiatry. 1996; 169 322-328
23 Tew J D, Mulsant B H, Haskett R F, Prudic J, Thase M E, Crowe R R, Dolata D, Begley A E, Reynolds C F, Sackeim H A. Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry. 1999; 156 1865-1870
24 Wesson L M, Wilkinson A M, Anderson D N, McCracken C. Does age predict long-term outcome of depression treated with ECT? (a prospective study of the long-term outcome of ECT-treated depression with respect to age). Int J Geriatr Psychiat. 1997; 12 45-51
25 Shapira B, Lerer B. Speed of response to bilateral ECT: An examination of possible predictors in two controlled trials. J ECT. 1999; 15 202-206
26 Grunhaus L, Shipley J E, Eiser A, Pande A C, Tandon R, Remen A, Greden J F. Polysomnographic studies in patients referred for ECT: pre-ECT studies. Convulsive Ther. 1997; 12 224-231
27 DeQuardo J R, Oladapo T, Brunberg J A, Rajiv T. Does neuroanatomy predict ECT response?. Prog Neuro-Psychopharmacol & Biol Psychiat. 1997; 21 1339-1352
28 Gupta N, Avasthi A, Kulhara P. Response to first ECT in depression: A predictor of outcome?. Indian J Psychiatry. 1998; 40 322-326
29 Anrade C. Prediction of antidepressant efficacy from response to the first ECT. Indian J Psychiatry. 1998; 40 394-395
30 Beale M D. Stimulus dosing methods in electroconvulsive therapy. Psychiatr Ann. 1998; 28 510-511
31 Sackeim H A. Pulse with and frequency of ECT. J ECT. 1999; 15 288-289
32 Schwartz C M, Manly D T. Efficiency of the stimulus characteristics of ECT. Am J Psychiatry. 2000; 157 1504-1506
33 Abrams R. ECT stimulus parameters as determinants of seizure quality. Psychiatr Ann. 1996; 26 701-704
34 Pisvejc J, Hyrman V, Sikora J, Berankova A, Kobeda B, Auerova M, Sochorova V. A comparison of brief and ultrabrief pulse stimuli in unilateral ECT. J ECT. 1998; 14 68-75
35 Harrigan P. Debate on ECT use in depression continues. Lancet. 1999; 354 401
36 Beale M D, Kellner C H, Pritchett J T, Bernstein H J, Bruns C M, Knapp R. Stimulus dose-titration in ECT: a 2-year clinical experience. Convulsive Ther. 1994; 10 171-176
37 Beale M D, Kellner C H. Proposed titration schedule. Convulsive Ther. 1997; 13 44
38 Sackeim H A, Prudic J, Devanand D P, Nobler M S, Lisanby S H, Peyser S, Fitzsimons L, Moody B J, Clark J. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry. 2000; 57 425-434
39 Fink M, Bailine S, Petrides G. Electrode Placement and Electroconvulsive Therapy: The Search for the Chimera. Arch Gen Psychiatry. 2001; 58 607-609
40 Fink M. Energy dosing in ECT: threshold stimulation or formula?. Convulsive Ther. 1997; 13 4-6
41 Weiner R D. Stimulus dosing with ECT: to titrate or not to titrate - that is the question. Convulsive Ther. 1997; 13 7-9
42 Petrides G, Fink M. The “half-age” stimulation strategy for ECT dosing. Convulsive Ther. 1996; 12 138-146
43 Folkerts H W. Elektrokrampftherapie. Untersuchungen zum Monitoring, zur Effektivität und zum pathischen Aspekt. Darmstadt: Steinkopff 1999
44 Girish K, Mayur P M, Saravanan E SM, Janakiramaiah N, Gangadhar B N, Subbakrishna D K, Umamaheswara Rao G S. Seizure threshold estimation by formula method: a prospective study in unilateral ECT. J ECT. 2000; 16 258-262
45 Vaughn McCall W, Reboussin D M, Weiner R D, Sackeim H A. Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy. Arch Gen Psychiatry. 2000; 57 438-444
46 McCall W V, Shelp F E, Weiner R D, Austin S, Norris J. Convulsive threshold differences in right unilateral and bilateral ECT. Biol Psychiatry. 1993; 34 606-611
47 Coffey C E, Lucke J, Weiner R D, Krystal A D, Aque M. Seizure threshold in electroconvulsive therapy (ECT) II. The anticonvulsant effect of ECT. Biol Psychiatry. 1995; 37 777-788
48 Girish K, Prasad K MR, Gangadhar B N, Janakiramiah N, Subbakrishna D K, Parameshwara G. Clinical predictors of seizure threshold in bilateral ECT. Indian J Psychiatry. 1998; 40 327-330
49 Mayur P M, Subbakrishna D K, Gangadhar B N, Girish K, Janakiramaiah N, Rajam K K. Predicting seizure threshold at first ECT: a discriminant analysis study. NIMHANS. 1998; 16 193-196
50 Krystal A D, Weiner R D, McCall W V, Shelp F E, Arias R, Smith P. The effects of ECT stimulus dose and electrode placement on the ictal electroencephalogram: An intraindividual crossover study. Biol Psychiatry. 1993; 34 759-767
51 Nobler M S, Sackeim H A, Solomou M, Luber B, Devenand D P, Prudic J. EEG manifestations during ECT: Effects of electrode placement and stimulus intensity. Biol Psychiatry. 1993; 34 321-330
52 Sackeim H A, Devenand D P, Prudic J. Stimulus intensity, seizure threshold, and seizure duration: impact on the efficacy and safety of electroconvulsive therapy. Psychiatr Clin North Am. 1991; 14 803-843
53 Krystal A D, Weiner R D. ECT seizure therapeutic adequacy. Convulsive Ther. 1994; 10 153-164
54 Krystal A D, Weiner R D, Coffey C E. The ictal EEG as a marker of adequate stimulus intensity with unilateral ECT. J Neuropsychiatry Clin Neurosci. 1995; 7 295-303
55 Suppes T, Webb A, Carmody T, Gordon E, Gutierrez-Esteinou R, Hudson J I, Pope Jr H G. Is postictal silence a predictor of response to electroconvulsive therapy?. J Affect Disord. 1996; 41 55-58
56 Gangadhar B N, Subbakrishna D K, Janakiramaiah N, Motreja S, Dutt D N, Paramehwara G. Post-seizure EEG fractal dimension of first ECT predicts antidepressant response at two weeks. J Affect Disord. 1999; 52 235-238
57 Anrade C. Assessment of the therapeutic adequacy of the ECT seizure: current status. NIMHANS. 1997; 15 319-329
58 Abrams R, Schwartz C M. Thymatron-IV. Beschreibung und Bedienungsanleitung. Taufkirchen: Fred Berninger Importe 1999
59 Freeman C P. The ECT Handbook. The Second Report of the Royal College of Psychiatrists' Special Committee on ECT. Dorchester: Dorset Press 1995
60 Bailine S H, Rifkin A, Kayne E, Jeffrey A, Selzer J A, Vital-Herne J, Blieka M, Pollack S. Comparison of bifrontal and bitemporal ECT for major depression. Am J Psychiatry. 2000; 177 121-123
61 Krystal A D, Dean M D, Weiner R D, Tramontozzi L A, Connor K M, Lindahl V H, Massie R W. ECT stimulus intensity: are present ECT devices too limited?. Am J Psychiatry. 2000; 157 963-967
62 Gangadhar B N, Janakiramaiah N, Subbakrishna D K, Praveen J, Reddy A K. Twice versus thrice weekly ECT in melancholia: a double-blind prospective comparison. J Affect Disord. 1993; 27 273-278
63 Shapira B, Tubi N, Drexler H, Lidsky D, Calev A, Lerer B. Cost and benefit in the choice of ECT schedule. Br J Psychiatry. 1998; 172 44-48
64 Vieweg R, Shawcross C R. A trial to determine any difference between two and three times a week ECT in the rate of recovery from depression. J Mental Health. 1998; 7 403-409
65 Abrams R. The mortality rate with ECT. Convulsive Ther. 1997; 13 125-127
66 Thorogood M, Cown P, Mann J, Murphey M, Vessey M. Fatal myocardial infarction and use of psychotropic drugs. Lancet. 1992; 340 1067-1070
67 Beukelmann D. Antihypertensiva. In: Kochs E, Krier C, Buzello W, Adams HA (Hrsg). Anästhesiologie Stuttgart, New York: Thieme 2001: 286
68 Stern L, Hirschmann S, Grunhaus L. ECT in Patients with major depressive disorder and low cardiac output. Convulsive Ther. 1997; 13 68-73
69 Nemes C, Niemer M, Noak G. Datenbuch Anästhesiologie. Stuttgart, New York: G. Fischer 1985: 78
70 Modica P A, Templehoff R, White P F. Pro- and anticonvulsant effects of anesthetics (Part II). Anesth Analg. 1990; 70 433-444
71 Nadstawek J, Lier H, Thees Ch. Epilepsie. In: Kochs E, Krier C, Buzello W, Adams HA (Hrsg). Anästhesiologie Stuttgart, New York: Thieme 2001: 886
72 Hering W, Schüttler J. Intravenöse Anästhetika. In: Kochs E, Krier C, Buzello W, Adams HA (Hrsg). Anästhesiologie Stuttgart, New York: Thieme 2001: 219-220
73 Möllenberg O. Psychiatrie. In: Kochs E, Krier C, Buzello W, Adams HA (Hrsg). Anästhesiologie Stuttgart, New York: Thieme 2001: 1279
74 Simpson K H. et al . Propofol reduces seizure duration in patients having anesthesia for electroconvulsive therapy. Br J Anesth. 1988; 61 343-344
75 Swartz C M. Propofol anesthesia in ECT. Convuls Ther. 1992; 8 262-266
76 Produktmonographie Disoprivan. Zeneca. DI 12 (1/94) 5D 71-72
77 Motsch J, Böttiger B W, Bock M. Muskelrelaxantien - Pharmakologie und klinischer Einsatz. Anästhesiologie & Intensivmedizin. 2001; 42 237-253
78 Devanand D P, Dwork A J, Hutchinson E R, Bolwig T G, Sackeim H A. Does ECT alter brain structure?. Am J Psychiatry. 1994; 151 957-970
79 Ende G, Braus D F, Walter S, Weber-Fahr W, Henn F A. The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Arch Gen Psychiatry. 2000; 57 937-943
80 Scott B W, Wojtowicz J M, Burnham W M. Neurogenesis in the dentate gyrus of the rat following electroconvulsive shock seizures. Exp Neurol. 2000; 165 231-236
81 Madsen T M, Treschow A, Bengzon J, Bolwig T G, Lindvall O, Tingstrom A. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry. 2000; 15 1043-1049
82 Duman R S, Vaidya V A. Molecular and cellular actions of chronic electroconvulsive therapy. J ECT. 1998; 14 181-193
83 Jowsey S G. The effect of medications on ECT. Psychiatr Ann. 1993; 23 33-37
84 Grunhaus L, Dolberg O, Lustig M. Relapse and recurrence following a course of ECT: reasons for concern and strategies for further investigation. J Psychiat Res. 1995; 29 165-172
85 Kellner C H, Bourgon L N. Combining ECT and antidepressants: time to reassess. J ECT. 1998; 14 65-67
86 Hamner M, Huber M. Discontinuation of antidepressant medications before ECT. Convulsive Ther. 1996; 12 125-126
87 Potokar J, Wilson S, Nutt D J. Do SSRIs prolong seizure duration during ECT?. International Journal of Psychiatry in Clinical Practice. 1997; 1 277-280
88 Prichtett J T, Bernstein H J, Kellner C H. Combined ECT and antidepressant drug therapy. Convulsive Ther. 1993; 9 256-261
89 Krahn L E, Hanson C A, Pileggi T S, Rummans T A. Electroconvulsive therapy and cardiovascular complications in patients taking Trazodone for insomnia. J Clin Psychiatry. 2001; 62 108-110
90 Pettinati H M, Stephens R N, Willis K M, Robin S. Evidence for less improvement in depression in patients taking benzodiazepines during unilateral ECT. Am J Psychiatry. 1990; 147 1029-1035
91 Guthrie S A, Sung J C-Y, Goodson R N, Grunhaus L, Tandon R. Triazolam and Diphenhydramine effects on seizure duration in depressed patients receiving ECT. J Convulsive Ther. 1996; 12 261-265
92 Krystal A D, Watts B V, Weiner R D, Moore S, Steffens D C, Lindahl V. The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient. J ECT. 1998; 14 5-14
93 Klapheke M M. Combining ECT and antipsychotic agents: benefits and risks. Convulsive Ther. 1993; 9 241-255
94 Kelsey M C, Grossberg G T. Safety and efficacy of caffeine-augmented ECT in elderly depressives: a retrospective study. J Geriatr Psychiatry Neurol. 1995; 8 168-172
95 Lisanby S H, Maddox J H, Prudic J, Devanand D P, Sackeim H A. The Effect of Electroconvulsive Therapy on Memory of Autobiographical and Public Events. Arch Gen Psychiatry. 2000; 57 581-590
96 Coleman E A, Sackeim H A, Prudic J, Devenand D P, McElhiney M C, Moody B J. Subjective memory complaints prior and following electroconvulsive therapy. Biol Psychiatry. 1996; 39 346-356
97 Prudic J, Peyser S, Sackeim H A. Subjective memory complaints: a review of patient self-assessment of memory after electroconvulsive therapy. J ECT. 2000; 16 121-132
98 Cohen D, Taieb O, Flament M, Benoit N, Chevret S, Corcos M, Fossati P, Jeammet P, Allilaire J-F, Basquin M. Absence of cognitive impairment at long-term follow-up in adolescents treated with ECT for severe mood disorder. Am J Psychiatry. 2000; 157 460-462
99 Coffey C E. The pre-ECT evaluation. Psychiatr Ann. 1998; 28 506-508
100 Sackeim H A, Haskett R F, Mulsant B H, Thase M E, Mann J J, Pettinati H M, Greenberg R M, Crowe R R, Cooper T B, Prudic J. Continuation Pharmacotherapy in the Prevention of Relapse Following Electroconvulsive Therapy. A Randomized Controlled Trial. JAMA. 2001; 285 1299-1307
101 Sackeim H A. Continuation therapy following ECT: directions for future research. Psychopharmacol Bull. 1994; 30 501-521
102 Petrides G. Continuation ECT: a review. Psychiatr Ann. 1998; 28 517-523
103 Sackeim H, Prudic J, Devenand D P, Decina P, Kerr B, Malitz S. The impact of medication resistence and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol. 1990; 10 76-104
104 Prudic J M, Sackeim H A, Rifas S. Medication resistance, response to ECT, and prevention of relapse. Psychiatr Ann. 1994; 24 228-231
105 Petrides G, Dhossche D, Fink M, Francis A. Continuation ECT: relapse prevention in affective disorders. Convulsive Ther. 1994; 10 189-194
106 Clarke T, Coffey C, Hoffmann G, Weiner R. Continuation therapy for depression using outpatient electroconvulsive therapy. Convulsive Ther. 1989; 4 330-337
107 Jaffe R, Dubin W R, Roemer R. Continuation and maintenance ECT - efficacy and safety. Proceedings of the 142^nd Annual Meeting from the American Psychiatric Association, New Research Program and Abstracts. 1989
108 Jaffe R, Dubin W, Shoyer B, Roemer R, Sharon D, Lipschutz L. Outpatient electroconvulsive therapy: efficacy and safety. Convulsive Ther. 1990; 6 231-238
109 Schwarz T, Loewenstein R N, Isenberg K E. Maintenance ECT: Indications and outcome. Convulsive Ther. 1995; 11 14-23
110 Beale M D, Bernstein H J, Kellner C H. Maintenance electroconvulsive therapy for geriatric depression: a one year follow-up. Clinical gerontologist. 1996; 16 86-90
111 McDonald W M, Phillips V L, Figiel G S, Marsteller F A, Simpson C D, Bailey M C. Cost-effective maintenance treatment of resistant geriatric depression. Psychiatr Ann. 1998; 28 47-52
112 Kramer B A. A Naturalistic review of maintenance ECT at a university setting. J ECT. 1999; 15 262-269
113 Gagné G G, Furman M J, Carpenter L L, Price L H. Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry. 2000; 157 1960-1965
114 Swoboda E, Conca A, König P, Waanders R, Hausen M. Maintenance Electroconvulsive Therapy in Affective and Schizoaffective Disorder. Neuropsychobiology. 2001; 43 23-28
115 Wijkstra J, Nolen W A, Algra A, van Vliet I M, Kahn R S. Relapse prevention in major depressive disorder after successful ECT. A literature review and a naturalistic case series. Acta Psychiatr Scand. 2000; 102 454-460
116 Fink M, Kellner C H. A second quiet revolution: ambulatory ECT. Convulsive Ther. 1996; 12 1-2
117 Vanelle J-M, Loo H, Galinowski A, deCarvalho W, Bourdel M-C, Brochier P, Bouvet O, Brochier T, Olie J-P. Maintenance ECT in intractable manic-depressives disorders. Convulsive Ther. 1994; 10 195-205
118 Steffens D C, Krystal A D, Sibert T E, Moore S D, Weiner R D. Cost effectiveness of maintenance ECT. Convulsive Ther. 1995; 11 283-287

Dr. med. Dipl.-Psych. D. Klecha

Abteilung für Psychiatrie und Psychotherapie des Universitätsklinikums Freiburg

Hauptstr. 5

79104 Freiburg

eMail: dorothee_klecha@psyallg.ukl.uni-freiburg.de